Our study has provided an unprecedented view of the functional plasticity of resident stromal cells, commonly known as keratocytes (not to be confused with dermal epithelial keratinocytes). The keratocytes are responsible for the synthesis of corneal crystallins, stromal proteoglycans, and interstitial fibrillar collagens.
7 14 However, in culture, the cells downregulate these corneal housekeeping genes, as we have shown, and switch on a repertoire of macrophage genes, implying that as a first response to injury or infection of the cornea, keratocytes become macrophage-like. An earlier demonstration of phagocytosis in cultured corneal keratocytes and antigen-presentation functions further supports a macrophage identity for stromal keratocytes.
36 37 Thus, stromal keratocytes may have a dual function in the cornea: one of synthesizing stromal proteins for a transparent resting cornea and a second of immunoprotection on injury and infection. This discovery raises new questions about the identity of corneal stromal keratocytes. Although, these cells have macrophage characteristics, they do not appear to be of bone marrow–derived monocyte lineage. First, these keratocytes do not express the bone marrow monocyte derivative marker F4/80 antigen, as indicated by our gene expression and immunofluorescence results
(Fig. 6) and studies by Seo et al.
37 Second, we detected MHC class I, but not MHC class II transcripts. Seo et al. detected MHC class II antigens only after inducing keratocytes with interferon-γ. Our keratocyte primary cultures expressed the known markers prostaglandin D2 synthase, keratocan, and lumican, another stromal proteoglycan
(Fig. 6) , allaying our concern that these may be cells other than those commonly known as keratocytes. In addition, they expressed genes of neural crest origin (ephrin B2, paired box gene 6), suggesting that these are indeed derived from the neural crest during embryonic development
38 and are distinct from the recently discovered bone marrow–derived cells in the cornea.
39 40 To maintain a transparent, refractive surface for vision, the cornea must restrict inflammation and create an immunosuppressive microenvironment without compromising tissue integrity against injury and infection.
3 Consistent with this need, MHC class II, but not MHC class I, antigens are generally low in the cornea, to minimize effecter T-cell–mediated inflammation. A further adaptation to this requirement is the macrophage-like nature of the stromal keratocytes, constitutively MHC class II negative, yet capable of MHC class I antigen presentation and innate defense.